Overview

A Single Dose Escalation Study of HHT201 in Healthy Subjects

Status:
NOT_YET_RECRUITING
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and pharmacokinetic profiles of HHT201 in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
Treatments:
Injections